Möchten Sie immer auf dem neuesten Stand bleiben?

Dublin, March 03, 2026 (GLOBE NEWSWIRE) -- The "Battery Passport Market by Industry, Battery Type, Technology, End User, Business Model, Region - Global Forecast to 2035" report has been added to ...

-- Studies highlight the clinical effectiveness of EXPAREL for total knee arthroplasty and long-term pain management with ioveraº for patients with osteoarthritis (OA) of the knee -- -- Data...

Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease Designation based on positive data from a phase 2 study of rilzabrutinib in IgG4-RDThird global orphan drug...

The partnership aims to accelerate the digital transformation and enhancement of chronic disease services through the application of AI.

‒ Full Year 2025 Performance Met or Exceeded All Guidance Metrics and 2026 Reflects Another Year of Growth – ‒ Q4 2025 Net Revenue of $814 million; GAAP Net Income of $35 million; Diluted Income per...

Pratteln, Switzerland, February 27, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announces that the Spanish Interministerial Commission on Prices of Medicines, has proposed to include AGAMREE®...

— Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years — — Conference call today at 4:30 p.m. ET — BRISBANE, Calif., Feb. 26,...

HMG Strategy’s 2026 Phoenix Summit unites C-level tech leaders to explore AI, disruption, and iconic leadership shaping the enterprise of 2030

Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million Achieved record net revenue in Q4 2025 and FY 2025 ...

Ligand Reports Fourth Quarter and Full Year 2025 Financial Results